SynthesisBMC medicine2020

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis.

Xiaoxiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.